N-tert-Butyl-2-[3-(trifluoromethyl)benzoyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide

Catalog No. :
ACCVMK643
CAS No. :
318256-36-9
Molecular Formula :
C22H23F3N2O2
Molecular Weight :
404.43

IUPAC Name:N-(tert-butyl)-2-(3-(trifluoromethyl)benzoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide

N-tert-Butyl-2-[3-(trifluoromethyl)benzoyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-tert-Butyl-2-[3-(trifluoromethyl)benzoyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
IUPAC NameN-(tert-butyl)-2-(3-(trifluoromethyl)benzoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
MDL No.MFCD01316019
Molecular FormulaC22H23F3N2O2
Molecular Weight404.43
SMILESO=C(C1N(C(C2=CC=CC(C(F)(F)F)=C2)=O)CC3=C(C=CC=C3)C1)NC(C)(C)C
InChI KeyRDPJXVSRODQWIW-UHFFFAOYSA-N
SynonymN-(TERT-BUTYL)-2-[3-(TRIFLUOROMETHYL)BENZOYL]-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBOXAMIDE;N-tert-butyl-2-[3-(trifluoromethyl)benzoyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide;3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)-1,2,3,4-tetrahydro-2-[3-(trifluoromethyl)benzoyl]-
CAS No.318256-36-9

Synthetic Route by SureRoute

1. ACCVMK643 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPLCQ651 route compound structure diagram
    ACPLCQ65160469-70-7
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCVMK643 route product structure diagram
    ACCVMK643318256-36-9
Inquiry

2. ACCVMK643 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDBVL234 route compound structure diagram
    ACDBVL234153290-82-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCVMK643 route product structure diagram
    ACCVMK643318256-36-9
Inquiry

Comments (0)